Other
Press Release - Liverpool launches new Centre of Excellence for Long-acting Therapeutics
University of Liverpool has launched a new research centre for the development of revolutionary long-acting medicines.
What is it about?
The Centre of Excellence in Long-acting Therapeutics (CELT) is a cross-faculty research initiative at the University of Liverpool, combining world leading expertise in pharmacology and materials chemistry and working with international partners to disseminate research findings in long-acting medicine and change the global landscape of drug administration.
Why is it important?
Long-acting therapeutics can have a huge impact for treatment and prevention of chronic diseases but also other applications for acute diseases where multiple pharmaceutical doses are required for successful therapy. We intend to implement impactful solutions to the critical challenges that affect those suffering from these diseases and work with partners to better understand how these technologies can be of most benefit.
CELT aims to provide a better understanding for a range of technologies, to develop new interventions and harmonise strategies to accelerate long-acting therapeutic development and implementation. We are collaborating globally with industrial, academic and charitable partners as well as patients and doctors, and are keen to establish new links to programmes that aim to deliver clear patient benefits.
Perspectives
CELT offers the integration of new materials chemistry with leading pharmacological evaluation of efficacy and safety. As such, we aim to produce novel opportunities that are embedded in the foundation of clinical relevance and multidisciplinary mechanistic understanding, accelerate the translation to deliverable patient benefits and further the global understanding of long-acting therapeutics.
